NextCure Inc
(FRA:2US)
€
1.26
-0.018 (-1.49%)
Market Cap: 35.51 Mil
Enterprise Value: -39.95 Mil
PE Ratio: 0
PB Ratio: 0.45
GF Score: 36/100 NextCure Inc Updated Clinical Data from NC318 Phase 1/2 Clinical Trial Presentation Transcript
Nov 09, 2019 / 11:30PM GMT
Michael Richman
NextCure - President and Chief Executive Officer
Presentation
Nov 09, 2019 / 11:30PM GMT
=====================
Corporate Participants
=====================
* Michael Richman
NextCure - President and Chief Executive Officer
* Kevin Heller
NextCure - Chief Medical Officer
=====================
Conference Call Participants
=====================
* Jeffrey Hung
Morgan Stanley - Analyst
* Chad Messer
Needham & Company - Analyst
* Alec Stranahan
Bank of America Merrill Lynch - Analyst
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot